Product Images Penbraya
View Photos of Packaging, Labels & Appearance
- Vial - penbraya 01
- Syringe - penbraya 02
- Vial adapter - penbraya 03
- Step 1 - penbraya 04
- Step 2 - penbraya 05
- Step 3 - penbraya 06
- Step 4 - penbraya 07
- Step 5 - penbraya 08
- Step 6 - penbraya 09
- Step 7 - penbraya 10
- Step 8 - penbraya 11
- Step 9 - penbraya 12
- Step 10 - penbraya 13
- Logo - penbraya 14
- PRINCIPAL DISPLAY PANEL - 1 Vial/Syringe Kit Carton - pentavalent 13
- PRINCIPAL DISPLAY PANEL - 5 Vial/Syringe Kit Carton - pentavalent 14
- PRINCIPAL DISPLAY PANEL - 10 Vial/Syringe Kit Carton - pentavalent 15
- PRINCIPAL DISPLAY PANEL - 1 Vial Label - pentavalent 16
- PRINCIPAL DISPLAY PANEL - 1 Syringe Label - pentavalent 17
Product Label Images
The following 19 images provide visual information about the product associated with Penbraya NDC 0069-0600 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Syringe - penbraya 02
Luer lock adapter is a commonly used medical device accessory. It is designed to securely connect different medical equipment or devices together. The adapter features a male Luer lock connector on one end and a female Luer lock connector on the other end. This allows for a reliable and leak-free connection between various medical components, such as syringes, catheters, and IV lines. The Luer lock mechanism ensures that the connection remains secure during medical procedures, preventing accidental disconnections and minimizing the risk of contamination. Overall, the Luer lock adapter is an essential tool in medical settings for ensuring safe and efficient medical equipment connections.*
PRINCIPAL DISPLAY PANEL - 1 Vial Label - pentavalent 16
This text appears to be a description of a lyophilized (freeze-dried) component with the National Drug Code (NDC) 0069-0271-01. It is specifically mentioned that this MenACWY Component should not be used alone and should be reconstituted with the MenB Component to form a Meningococcal Group A, B, C, W, and Y Vaccine called PENBRAYA™. The recommended dose after reconstitution is approximately 0.5 mL. The text ends with the code PAA212956.*
PRINCIPAL DISPLAY PANEL - 1 Syringe Label - pentavalent 17
This text appears to be a description of a vaccine called "PENBRAYA™" manufactured by Pfizer Ireland. It is a combination of two components: MenB and MenACWY. The vaccine is used to prevent meningococcal infections caused by groups A, B, C, W, and Y. The text also mentions that the MenB component should not be used alone and needs to be mixed with the Lyophilized MenACWY component before administration. It provides a lot number and expiration date, indicating the batch information for the product. Additionally, it instructs to shake the mixture well before use.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.